Insider · CIK 0001738144
Janet Dorling
Files at CBAY (CymaBay Therapeutics, Inc.). First filing Nov 14, 2023, latest Feb 14, 2024.
In brief
Janet Dorling files SEC Form 4 as director at CBAY (CymaBay Therapeutics, Inc.). Since Nov 14, 2023, Janet Dorling has reported 0 open-market buys worth $0 and 4 open-market sells worth $562k, the latest filed on Feb 14, 2024.
A track record needs three past buys with six months of prices behind them; Janet Dorling has 0, so none is measured yet.
The newest scored trade: sold $192k of CBAY on Feb 12, 2024, filed Feb 14, 2024, scored 12 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 12Weak | CymaBay Therapeutics, Inc. | $192k 6,000 shares | -100% | - | |
| 26Weak | CymaBay Therapeutics, Inc. | $143k 6,000 shares | -100% | - | |
| 25Weak | CymaBay Therapeutics, Inc. | $120k 6,000 shares | -100% | - | |
| 25Weak | CymaBay Therapeutics, Inc. | $107k 7,000 shares | -100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 12, 2024 | CBAY CYMABAY THERAPEUTICS, INC. | 6,000 0.01% of outstanding | $192k | Feb 12, 2024 | $264k |
| Jan 10, 2024 | CBAY CYMABAY THERAPEUTICS, INC. | 6,000 0.01% of outstanding | $143k | Jan 10, 2024 | $227k |
| Dec 11, 2023 | CYMABAY THERAPEUTICS, INC. | 6,000 0.01% of outstanding | $120k | Dec 11, 2023 | $107k |
| Nov 13, 2023 | CYMABAY THERAPEUTICS, INC. | 7,000 0.01% of outstanding | $107k | Nov 10, 2023 | none |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -55,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -67,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -14,010 | - | - | 0 | Mar 22, 2024 |
| Feb 12, 2024 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,000 | $4.63 | $28k | 6,000 | Feb 14, 2024 |
| Feb 12, 2024 | CBAY CymaBay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $31.97 | $192k | 0 | Feb 14, 2024 |
| Feb 12, 2024 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 55,000 | Feb 14, 2024 |
| Jan 24, 2024 | CBAY CymaBay Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +14,010 | $0.00 | $0 | 14,010 | Jan 26, 2024 |
| Jan 10, 2024 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,000 | $4.63 | $28k | 6,000 | Jan 10, 2024 |
| Jan 10, 2024 | CBAY CymaBay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $23.86 | $143k | 0 | Jan 10, 2024 |
| Jan 10, 2024 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 61,000 | Jan 10, 2024 |
| Dec 11, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,000 | $4.63 | $28k | 6,000 | Dec 11, 2023 |
| Dec 11, 2023 | CBAY CymaBay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $20.07 | $120k | 0 | Dec 11, 2023 |
| Dec 11, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 67,000 | Dec 11, 2023 |
| Nov 10, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +7,000 | $4.63 | $32k | 7,000 | Nov 14, 2023 |
| Nov 10, 2023 | CBAY CymaBay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -7,000 | $15.24 | $107k | 0 | Nov 14, 2023 |
| Nov 10, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -7,000 | $0.00 | $0 | 73,000 | Nov 14, 2023 |
Questions about Janet Dorling
Answered from the filings on this page, as of the latest one.
Is Janet Dorling buying or selling?
Not in the last 12 months. Janet Dorling's latest open-market trade on SEC Form 4 was sold $192k of CBAY on Feb 12, 2024.
How did Janet Dorling's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Janet Dorling has 0.
Where does Janet Dorling file Form 4?
Janet Dorling has filed Form 4 at CBAY (CymaBay Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.